GSTM1 and neoplasm: Fewer epoetin alfa-treated patients than placebo-treated patients in the ITT population were transfused after day 28 (24.7% vs 39.5%, P<0.01, Wald's χ2 test from logistic model correcting for tumour type and Hb stratum) (Littlewood et al, 2001).